Skip to content
VisionGate LogoVisionGate LogoVisionGate Logo
  • About
    • Our Team
  • Our Technology
    • Non-intrusive Testing
    • Patented Cell-CT Imaging
    • AI Powered Detection
  • Blog
  • Partner With Us
  • Contact
  • Am I At Risk?

News

  • NewsFPO
  • ResearchFPO
  • Publications
  • Diagnostic Tests
  • VisionGate Focuses on the Importance of Early Detection During Lung Cancer Awareness Month

    November 22, 2021

    News

  • VisionGate’s Breakthrough Lung Cancer Detection Technologies Help Save Lives

    October 27, 2021

    News

  • VisionGate’s New Website Illustrates its Mission to Save Lives through Early Detection of Lung Cancer

    September 22, 2021

    News

  • Results and Presentation of Important New Research at the 2018 IASLC World Conference on Lung Cancer

    September 28, 2018

    NewsPress Releases

  • VisionGate Lung Cancer 3D Cellular Imaging Research to be Featured as a Late-Breaking Abstract at the AACR Annual Meeting 2018

    April 12, 2018

    NewsPress ReleasesResearch

  • VisionGate is Leveraging the Cell-CT™ Platform to Expand Cancer Diagnostics Services

    April 5, 2018

    NewsResearch

  • New Research Study Demonstrates Applicability of 3-D Cell-CT™ Imaging and Analysis Platform

    December 12, 2017

    NewsPublicationsResearch

  • Advances in Lung Cancer Early Detection and Treatment at the World Conference on Lung Cancer

    October 6, 2017

    NewsResearch

  • Blinded Trial Data Could Help Alleviate Worry Over Incidental Lung Nodule Findings

    December 16, 2016

    NewsPress ReleasesResearch

  • 17th World Conference on Lung Cancer: VisionGate Will Present Twice!

    November 17, 2016

    News

  • VisionGate to Speak for the Exclusive Piper Jaffray Conference

    November 17, 2016

    News

  • VisionGate’s Alan Nelson Named Academy of Inventors Fellow

    April 28, 2016

    News

  • VisionGate Receives Strategic Investment from Trinnovate Ventures

    March 16, 2016

    News

  • VisionGate to Present at Leerink Partners Global Healthcare Conference

    February 5, 2016

    News

  • Phoenix Firefighters Get Free Lung-Cancer Testing

    December 4, 2015

    News

  • Making LIFE Better

    September 22, 2015

    NewsPublications

  • VisionGate’s LuCED Shows Promise for Lung Cancer Screening

    September 11, 2015

    NewsResearch

  • Significant Lung Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology

    July 9, 2015

    NewsPublications

  • VisionGate Receives Backing From Dignity Health in Arizona

    February 3, 2015

    News

  • VisionGate® Wins Two Gold Awards in the Best in Biz Awards 2014

    December 11, 2014

    News

  • VisionGate CEO and President Both Among Arizona’s Top Business Leaders

    November 24, 2014

    NewsPublications

  • New Data Demonstrates VisionGate’s LuCED® Test Able to Detect Early Cancer

    November 20, 2014

    NewsResearch

  • Lung Cancer Test Shows High Sensitivity, Specificity, and Early Stage Detection

    May 23, 2014

    News

  • VisionGate to Present Early Lung Cancer Detection Data at ASCO

    May 7, 2014

    News

  • Non-invasive Detection of Lung Cancer from Cells in Sputum Using Cell-CT™

    October 28, 2013

    NewsPublicationsResearch

  • VisonGate to Present at IASLC Meeting

    October 15, 2013

    NewsPublicationsResearch

  • Dr. Alan Nelson named Research Fellow at International Prevention Research Institute

    August 7, 2013

    News

  • VisionGate reports advances in it’s Cell-CT 3D cell analysis platform

    January 18, 2013

    NewsResearch

  • Medical Device Daily – VisionGate presents at OneMedForum 2012 Conference

    January 23, 2012

    NewsPublications

  • World’s First Biomedical Cell-CT™ Research Lab to Open

    September 10, 2010

    News

  • VisionGate, Inc. Announced Five Abstracts Describing its Cell-CT™ System for 3D Cellular Imaging

    August 24, 2010

    NewsResearch

  • VisionGate Receives $3 Million in Government Grants

    June 18, 2010

    News

  • Arizona State University’s Biodesign Institute Will Acquire the First Commercially Available Cell-CT™ Imaging Platform

    February 26, 2009

    News

  • VisionGate and Seattle Cancer Care Alliance Join Forces

    December 17, 2008

    News

  • Peer-reviewed Publication in Pattern Recognition Demonstrates Superiority of Cell-CT™

    September 29, 2008

    NewsPublicationsResearch

  • Swedish Cancer Institute Taking Part in Development of Cell-CT™ Platform for Lung Cancer Risk Assessment

    May 1, 2008

    News

visiongate logo retina logo

Follow Us

  • Home
  • About
  • Blog
  • Our Technology
  • Partner With Us
Contact

© Copyright 2005 – 2023 | VisionGate, Inc | Milwaukee Web Design by Flipeleven | All Rights Reserved

3 Questions to Assess Your Risk

 Early detection of lung cancer is important to keeping you healthy and living your life to the fullest.

Has a family member had Lung Cancer? *
Have you smoked or been exposed to secondhand smoke? *

If you are over the age of 60 or answer "Yes" to any of the questions above, you may be at an increased risk.

This test is not a diagnosis but can help you recognize factors that may increase your risk of developing lung cancer. Next, You can subscribe to learn more from VisionGate. Then, you'll be redirected to a page of resources that can aid you in discussions with your doctor, or click here to access the page directly.

If you are above the age of 50 and answered "Yes" to any of the questions, you may be at an increased risk of developing lung cancer, but this is not a diagnosis. Use the link below to download resources that can help you talk to your doctor. Click Here to Download
We're sorry! There was an error submitting the test. Please try again later.

*No personal information is collected or saved through this form without your consent. Only your email and name will be saved if you opt-in.

visiongate logo
Contact
  • Home
  • About
  • Blog
  • Our Technology
  • Partner With Us

© Copyright 2005 – 2023 | VisionGate, Inc | Milwaukee Web Design by Flipeleven | All Rights Reserved

Page load link
Go to Top